Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lowell Anthony

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Seminars in Oncology Nursing|January 2, 2004
New strategies for the prevention and reduction of cancer treatment-induced diarrheaLowell Anthony
Current Opinion in Supportive and Palliative Care|July 29, 2008
Irinotecan toxicityLowell Anthony
Current Opinion in Supportive and Palliative Care|August 8, 2008
Tyrosine kinase inhibitors and gut toxicity: a new era in supportive careDorothy Keefe, Lowell Anthony
Advances in Therapy|October 4, 2011
Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumorsWilliam H Ludlam, Lowell Anthony
Current Medical Research and Opinion|October 22, 2009
From somatostatin to octreotide LAR: evolution of a somatostatin analogueLowell Anthony, Pamela U Freda
Pancreas|June 24, 2011
Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year periodLowell Anthony, Aaron I Vinik
The American Journal of the Medical Sciences|January 15, 2019
Can a High-grade Neuroendocrine Carcinoma be Functional?Christopher Graham, Aman Chauhan, Lowell Anthony
Frontiers in Oncology|September 13, 2021
Management of Large Cell Neuroendocrine CarcinomaVirginia Corbett, Susanne Arnold, Lowell Anthony, et al.
Therapeutic Advances in Medical Oncology|June 29, 2026
Current and emerging therapies targeting cell surface antigens and epigenetics in extensive stage small cell lung cancer: primer for cliniciansZhonglin Hao, John Villano, Susanne M Arnold, et al.
Ochsner Journal|December 19, 2018
Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018Tanvir F Kabir, Aman Chauhan, Lowell Anthony, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Seminars in Oncology Nursing|January 2, 2004
New strategies for the prevention and reduction of cancer treatment-induced diarrheaLowell Anthony
Current Opinion in Supportive and Palliative Care|July 29, 2008
Irinotecan toxicityLowell Anthony
Current Opinion in Supportive and Palliative Care|August 8, 2008
Tyrosine kinase inhibitors and gut toxicity: a new era in supportive careDorothy Keefe, Lowell Anthony
Advances in Therapy|October 4, 2011
Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumorsWilliam H Ludlam, Lowell Anthony
Current Medical Research and Opinion|October 22, 2009
From somatostatin to octreotide LAR: evolution of a somatostatin analogueLowell Anthony, Pamela U Freda
Pancreas|June 24, 2011
Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year periodLowell Anthony, Aaron I Vinik
The American Journal of the Medical Sciences|January 15, 2019
Can a High-grade Neuroendocrine Carcinoma be Functional?Christopher Graham, Aman Chauhan, Lowell Anthony
Frontiers in Oncology|September 13, 2021
Management of Large Cell Neuroendocrine CarcinomaVirginia Corbett, Susanne Arnold, Lowell Anthony, et al.
Therapeutic Advances in Medical Oncology|June 29, 2026
Current and emerging therapies targeting cell surface antigens and epigenetics in extensive stage small cell lung cancer: primer for cliniciansZhonglin Hao, John Villano, Susanne M Arnold, et al.
Ochsner Journal|December 19, 2018
Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018Tanvir F Kabir, Aman Chauhan, Lowell Anthony, et al.
Pageof 5